The Journey Towards a Fully Automated Factory: Lessons Learned from The Creation of Sanofi’s Building 100

Synopsis

• Understanding the role of Sanofi’s Building 100 (B100) as one of Canada’s first biopharmaceutical smart factories to approach commercialization.
• Evaluating the project: Major triumphs, challenges and mitigations when developing, securing, and optimizing the processes/products within B100.
• Integrating bioprocessing schema within an automated environment
• The importance of process analytical technologies (PAT) to provide real-time diagnostics

Eric Doerr, Senior Project Lead M100 MSAT, Sanofi
Katerina Sarkovski, Director, B100 Manufacturing Technology Leader, Industrial Affairs, Sanofi